2024-511405-27-00CompletedPhase 1
A Multiple-Ascending-Dose Study of MK-1708 in Healthy Participants
Source: EU CTIS (euclinicaltrials.eu) · Last updated 30 Aug 2024
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 32 (actual)
- First submitted
- 15 Mar 2024
- Start date
- 8 May 2024
- Lead sponsor
- Merck Sharp & Dohme LLC
- Diseases
- ALS (motor neurone disease)
- EU CT number
- 2024-511405-27-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 32
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| SGS Belgium Coordinator of this site? Confirm its status | Edegem | Belgium | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.